ArticleCancer medicine2023
Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis.
Yun Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleCancer medicine2023
Yun Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.